Principal Investigator
Marijo Bilusic
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230098
Clinical Trial Summary
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
305-243-2647